Advanced Technologies and Treatment for Diabetes (ATTD)

Learning objectives

You will learn current approaches and innovations regarding:

• The utility of artificial intelligence in the care of people living with diabetes
• Delaying the onset of type 1 diabetes (T1DM) in high-risk individuals through screening, monitoring and use of disease-modifying teplizumab therapy
• The role of impaired hypoglycaemia awareness in severe hypoglycaemia among patients with T1DM or insulin-treated type 2 diabetes (T2DM)
• Use of the glycaemic risk index in a primary care setting
• Use of continuous glucose monitoring in T2DM treated with basal insulin and the efficacy of iGlarLixi.